Thank you, Mr. Chair.
Welcome to our witnesses. This is an interesting and I think extremely important discussion that we've started here. There seem to be some inconsistencies. I think everyone on the committee would be in agreement that we're looking to—let me say that I don't think anyone is against protecting intellectual property. The questions are for how long you protect it and how it affects other industries.
Ms. Benczkowski, you made a comment that we rank 23rd out of 29 of the OECD countries in innovation. Yet at the same time, you said that 5% of the new Alzheimer's drugs come out of Canada. That doesn't seem to jibe somehow. There is a disconnect there. It would seem that we actually are more than pulling our weight in innovation without any proposed changes if we're inventing 5% of the new drugs that are coming on the market.